Imatinib attaches to the active site of tyrosine kinase and blocks its activity. Imatinib is the first new substance that inhibits only specific enzymes in specific cancers without killing all rapidly dividing cells in an unspecific manner, and has become an example for other targeted therapies that inhibit tyrosine phosphatase. Imatinib, also called Gleevec, is used in chemotherapy to treat diseases such as cancer, chronic myelogenous leukemia (CML), and acute lymphocytic leukemia (ALL).

Visit us- https://www.medixocentre.com/gleevec-imatinib-price